ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® Injectable For The Treatment Of Osteoarthritis Of The Knee
March 29, 2018MiMedx Group, Inc. today announced that the first patient has been enrolled in the Company's Phase 2B Investigational New Drug (IND) clinical trial -
MiMedx Announces the Enrollment of the First Patients in the Phase III Clinical Trial of AmnioFix In
January 18, 2018MiMedx Announces First Trial Patients Are Randomized Into Phase Three MiMedx's Micronized Amniotic AmnioFix® Injectable Investigational New Drug (IND) Clinical Trial for Treating Achilles Tendonitis. -
MiMedx to divest Stability Biologics business to focus on biopharma
August 23, 2017MiMedx Group has signed a new definitive agreement with former stockholders of Stability to sell its subsidiary, Stability Biologics, back to the stockholders to focus on biopharma.
Pharma Sources Insight January 2025
